A scientist in a lab coat using the latest medical equipment for nucleic acid purification. Qiagen NV (NYSE:QGEN) is a leading provider of sample and assay technologies for molecular diagnostics ...

Qiagen N.V., a Netherlands-based medical diagnostics provider, faces market pressure due to some recent NIH funding concerns, despite strong financials and a diverse product portfolio. The company ...

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported fourth-quarter net income of $88.3 million. On a per-share basis, the Pl Venlo, Netherlands ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Qiagen NV (Symbol: QGEN) entered into oversold territory, hitting an RSI reading of 29.8 ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

The FDA has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding the company’s syndromic ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second ...